Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of genetic substructuring of statistical forensic parameters on genetic short tandem repeat markers in the populations of Southeastern Europe. | Croat Med J | 2022 | 35722693 | PubTator, text mining | PubMed |
| Expression Regulation of Water Reabsorption Genes and Transcription Factors in the Kidneys of Lepus yarkandensis. | Front Physiol | 2022 | 35721542 | PubTator, text mining | PubMed |
| Transactivation of TrkB Receptors by Oxytocin and Its G Protein-Coupled Receptor. | Front Mol Neurosci | 2022 | 35721318 | PubTator, text mining | PubMed |
| The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life. | Cureus | 2022 | 35719821 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor Maintains Vasopressin Responses in Kidney Collecting Duct Cells. | Front Physiol | 2022 | 35685285 | PubTator, text mining | PubMed |
| HOPX: A Unique Homeodomain Protein in Development and Tumor Suppression. | Cancers (Basel) | 2022 | 35681746 | PubTator, text mining | PubMed |
| Renal water transport in health and disease. | Pflugers Arch | 2022 | 35678906 | PubTator, text mining | PubMed |
| Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs. | Front Mol Biosci | 2022 | 35677880 | PubTator, text mining | PubMed |
| Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. | Signal Transduct Target Ther | 2022 | 35665742 | PubTator, text mining | PubMed |
| Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. | Front Pharmacol | 2022 | 35662736 | PubTator, text mining | PubMed |
| Paraventricular Nucleus V1a Receptor Knockdown Blunts Neurocardiovascular Responses to Acute Stress in Male Rats after Chronic Mild Unpredictable Stress. | Physiol Behav | 2022 | 35661787 | PubTator, text mining | PubMed |
| Effect of Ligands and Transducers on the Neurotensin Receptor 1 Conformational Ensemble. | J Am Chem Soc | 2022 | 35647863 | PubTator, text mining | PubMed |
| Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives. | Front Bioeng Biotechnol | 2022 | 35646840 | PubTator, text mining | PubMed |
| A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma. | Front Genet | 2022 | 35646063 | PubTator, text mining | PubMed |
| Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. | Int J Biol Sci | 2022 | 35637973 | PubTator, text mining | PubMed |
| Current Hydration Habits: The Disregarded Factor for the Development of Renal and Cardiometabolic Diseases. | Nutrients | 2022 | 35631211 | PubTator, text mining | PubMed |
| Structural Insights into the Intrinsically Disordered GPCR C-Terminal Region, Major Actor in Arrestin-GPCR Interaction. | Biomolecules | 2022 | 35625550 | PubTator, text mining | PubMed |
| Nanoluciferase-based complementation assay for systematic profiling of GPCR-GRK interactions. | Methods Cell Biol | 2022 | 35623709 | PubTator, text mining | PubMed |
| An Octopus-Derived Peptide with Antidiuretic Activity in Rats. | Mar Drugs | 2022 | 35621979 | PubTator, text mining | PubMed |
| Solvent-Free Synthesis of Core-Functionalised Naphthalene Diimides by Using a Vibratory Ball Mill: Suzuki, Sonogashira and Buchwald-Hartwig Reactions. | Chemistry | 2022 | 35621283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=27